Citation:Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M 1992

Citation

Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M. Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut 1992 Sep;33(9):1155-8 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1427364.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M 1992	What is the incidence of neoplasia in patients with BO?	Associate Professor Freddy Sitas	completed
Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M 1992 2	What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?	David Whiteman	completed
Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M 1992 3	Are there groups of patients with non-dysplastic BO that require more frequent surveillance?	Dr Henry To	completed
Iftikhar SY, James PD, Steele RJ, Hardcastle JD, Atkinson M 1992 4	Are there groups of patients with BO that can be discharged from surveillance?	Conjoint Associate Professor Philip Craig	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the incidence of neoplasia in patients with BO?|]] (compare critical appraisals)
• [[Clinical question:What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?|]] (compare critical appraisals)
• [[Clinical question:Are there groups of patients with non-dysplastic BO that require more frequent surveillance?|]] (compare critical appraisals)
• [[Clinical question:Are there groups of patients with BO that can be discharged from surveillance?|]] (compare critical appraisals)